<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is an <z:hpo ids='HP_0001548'>overgrowth</z:hpo> disorder characterized by developmental anomalies, tissue and organ <z:mpath ids='MPATH_134'>hyperplasia</z:mpath>, and an increased risk of <z:hpo ids='HP_0002898'>embryonal tumors</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>BWS is a multigenic disorder with dysregulation of the expression of imprinted genes involved in growth and cell cycle control in the 11p15 chromosomal region </plain></SENT>
<SENT sid="2" pm="."><plain>The molecular genetics appear to involve either mutations of imprinted genes or chromosomal alterations of a putative imprinting center that controls gene expression across a large chromosomal domain </plain></SENT>
<SENT sid="3" pm="."><plain>As the molecular genetics underlying BWS are unraveled, our knowledge of this imprinting disorder and its relationship to <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and developmental anomalies will be expanded </plain></SENT>
<SENT sid="4" pm="."><plain>Currently available diagnostic testing and follow-up protocols will evolve as our understanding of the molecular basis of this disease progresses </plain></SENT>
</text></document>